Clinical trials: not yet recruiting
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
huCART19-IL18-CD428z Cells for the Treatment of Patients With HIV With CD19+ Cancers
This research study is being conducted to evaluate an experimental drug called huCART19-IL18-CD428z cells in patients living with HIV who have been diagnosed with Non-Hodgkin Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL)…
- Conditions
- Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Richter's Transformation
- Trial name
- NCT07891468
- Testing
- huCART19-IL18-CD428z cells
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- University of Pennsylvania
Non-Small Cell Lung Cancer
A Phase 1 Trial of KAN-001 With Pembrolizumab, With or Without Chemotherapy, in Participants With PD-L1-Positive Non-Small Cell Lung Cancer
The goal of this Phase 1 clinical trial is to learn whether KAN-001, an investigational live biotherapeutic product, can be safely given with pembrolizumab, with or without chemotherapy, to adults with PD-L1-positive, inoperable…
- Trial name
- NCT07910942
- Testing
- KAN-001, Pembrolizumab
- Where
- 2 sites in United States, Canada
- Volunteers
- 40 people
- Sponsor
- Kanvas Biosciences
Type II Diabetes Mellitus
cfMSC Therapy for Diabetes
The purpose of this study is to assess the feasibility, safety and clinical efficacy of the novel clonal fetal mesenchymal stem cell (cfMSC) therapy in patients with type II diabetes mellitus.
- Trial name
- NCT07495956
- Testing
- cfMSC therapy for diabetes
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Shenzhen Geno-Immune Medical Institute
Equine-assisted Therapy, Addiction
The Impact of Equine-Assisted Therapy on Mental Health and Addictive Behaviors in Patients Receiving Addiction Treatment
Addiction is a major public health issue. According to the World Health Organization (2024), approximately 400 million people worldwide suffer from alcohol- or drug-related disorders, resulting in nearly 3.2 million deaths per…
- Conditions
- Equine-assisted Therapy, Addiction, Recidivism, Addictive Behaviors
- Trial name
- EQUI-ADDICT (NCT07495839)
- Testing
- Equine mediation
- Volunteers
- 22 people
- Sponsor
- Hopital La Musse
CT-Assessed Sarcopenia Outcomes
CT Based Assessment of Sarcopenia and Its Association With Biologic Treatment Outcomes in Inflammatory Bowel Disease Patients
Our study aims to investigate the incidence of sarcopenia in Patients with IBD using CT-based body composition parameters, observe the interaction between sarcopenia and IBD treatment, and determine whether sarcopenia affects the…
- Trial name
- Sarcopenia/IBD (NCT07482163)
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Assiut University
Diabetes Mellitus, Type 1 Diabetes, Cardiovascular Diseases (CVD)
Relationship Between Insulin Dose and Complications in Type 1 Diabetes
The goal of this observational study is to better understand how the amount of insulin people with type 1 diabetes are using relates to blood glucose control and the risk of complications.
- Conditions
- Diabetes Mellitus, Type 1 Diabetes, Cardiovascular Diseases (CVD), Severe Albuminuria, Estimated Glomerular Filtration Rate (eGFR)
- Trial name
- iDose-EDC (NCT07911033)
- Testing
- Routine/prescribed exogenous insulin dose
- Where
- United States
- Volunteers
- 80 people
- Sponsor
- Rachel Miller
Kidney Cancers, Prostate Cancer
Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate
The COMFORT study will evaluate an artificial intelligence-based platform developed to support the clinical assessment of kidney and prostate cancer.
- Trial name
- COMFORT (NCT07888322)
- Testing
- Medical Reading, AI assisted Medical reading
- Where
- 6 sites in Germany, Greece and 2 more
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Aristotle University Of Thessaloniki
Alcohol Use Disorder (AUD)
Connecting Online Military Personnel to Alcohol Harm-reducing Smartphone Support Study
The purpose of this research is to test the effectiveness of a free mobile phone app designed to help veterans improve their relationship with alcohol and reduce alcohol-related harms.
- Trial name
- COMPASS (NCT07911345)
- Testing
- VetChange (Explorer/Research version) Mobile App, Sober Time
- Volunteers
- 150 people
- Sponsor
- University of New Mexico
T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma
Universal 4SCAR7U Targeting CD7-positive Malignancies
The purpose of this clinical trial is to assess the feasibility, safety and efficacy of universal CAR T cells based on 4SCAR7U design against CD7-positive hematological malignancies using CD7 specific universal CAR T cells.
- Conditions
- T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia, NK Cell Lymphoma
- Trial name
- NCT05995028
- Testing
- Universal CD7-specific CAR gene-engineered T cells
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Shenzhen Geno-Immune Medical Institute
Feasibility Studies, Acceptability
Feasibility Study of a Relaxation and Guided Imagery Intervention Research Protocol for Use in School Settings.
The goal of this study is to gather information that (1) will be used to determine whether or not a research protocol for investigating the efficacy of a relaxation and guided imagery intervention for improving K-12 students'…
- Conditions
- Feasibility Studies, Acceptability, Pilot Study
- Trial name
- NCT07910695
- Testing
- Relaxation and Guided Imagery, Progressive Muscle Relaxation
- Volunteers
- 255 people, healthy volunteers welcome
- Sponsor
- Pace University
Cardiovascular Diseases
Cardiovascular Disease Multimorbidity
This is a hybrid type II effectiveness-implementation trial using a parallel cluster randomized design. Thirty primary healthcare centers (PHCs) in Akwa Ibom State, Nigeria, will be randomized in a 1:1 ratio to the implementation…
- Trial name
- NCT07909395
- Testing
- HEARTS, PF
- Where
- 2 sites in United States, Nigeria
- Volunteers
- 1,050 people
- Sponsor
- NYU Langone Health
Epilepsy, Glioma
Blood Brain Barrier Dysfunction in Glioma and Epileptogenesis
Gliomas are the most common and deadliest primary brain tumours in children and adults. Many people with glioma also develop epilepsy, which can be difficult to treat.
- Trial name
- Bridge (NCT07909460)
- Volunteers
- 56 people, healthy volunteers welcome
- Sponsor
- University College, London
Neurologic Disorders
Advanced Multisensorial System for Automatic Assessment of Neurological Disorders in Smart Spaces-URJC
Neurological diseases affect people's cognitive and physical abilities, limiting their functional independence and causing disability, which in many cases, is progressive and degenerative.
- Trial name
- NeurEYE-URJC (NCT07909824)
- Testing
- NEUREYE: healthy people, NEUREYE: people with neurological disease
- Where
- Spain
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Universidad Rey Juan Carlos
Dementia, Home Care for Elderly or Disabled Individuals
The Effectiveness of a Caregiver-Based Multicomponent Intervention to Prevent Pressure Ulcers in Home-Cared-For Individuals With Dementia
Introduction and Aim: Pressure ulcers are preventable complications that are common, particularly in individuals with dementia cared for at home, reducing quality of life and creating significant costs for the healthcare system.
- Conditions
- Dementia, Home Care for Elderly or Disabled Individuals, Decubitis Ulcer, Intervention
- Trial name
- NCT07843888
- Testing
- Pressure Injury Prevention Education
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Manisa Celal Bayar University
Healthy Individuals
Impact Of Aerobic Exercise on Sleep Quality and Postural Control Interplay Among University Students
The purpose of this study is to investigate the impact of moderate-intensity aerobic treadmill exercise on sleep quality and postural control interplay among university students with poor sleep quality.
- Trial name
- NCT07909980
- Testing
- Aerobic exercise Training, Sleep hygiene education
- Where
- Egypt
- Volunteers
- 66 people
- Sponsor
- Cairo University
Fluid Responsiveness, Laparoscopic Surgery
Fluid Responsiveness in Laparoscopic Surgery: End-Expiratory Occlusion Test Versus Mini-Fluid Challenge
Background Fluid management is central to perioperative care, but only about half of surgical patients increase their stroke volume after a fluid challenge.
- Conditions
- Fluid Responsiveness, Laparoscopic Surgery, Hemodynamic Monitoring
- Trial name
- FLUID-LAP (NCT07911059)
- Volunteers
- 104 people
- Sponsor
- University Of Perugia
Food Choices
Environmental Harm Menu Labels and Overall Dietary Quality
The primary objective of this study is to evaluate whether repeated exposure to environmental harm menu labels on fast-food restaurant menus changes overall dietary quality.
- Trial name
- MENU (NCT07910617)
- Testing
- Control (QR Code) Menu Labels, Traffic-Light Style Environmental Harm Menu Labels
- Where
- United States
- Volunteers
- 450 people, healthy volunteers welcome
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
B Cell Malignancies
CD19/22 Bi-specific CAR-T Cell Therapy
The purpose of this study is to assess the feasibility, safety and efficacy of anti-CD19/22 bi-specific CAR-T cell therapy in patients with CD19 and/or CD22 positive B cell malignancies.
- Trial name
- NCT05432882
- Testing
- bi-4SCAR CD19/22 T cells
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Shenzhen Geno-Immune Medical Institute
Chronic Obstructive Pulmonary Disease (COPD)
cfMSC Stem Cell Therapy Targeting COPD
The primary objectives are to evaluate the safety and efficacy of infusion of fully characterized clonally derived fetal mesenchymal stem cells (cfMSCs) for the control of severe symptoms associated with moderate to severe…
- Trial name
- NCT07477600
- Testing
- clonal fetal MSCs
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Shenzhen Geno-Immune Medical Institute
Mesothelin-Positive Advanced Solid Tumors With Peritoneal Metastasis
A Study of Mesothelin-Targeted CAR-Mix Cells in Patients With Advanced Solid Tumors
An exploratory, open-label, single-arm, dose-escalation clinical study evaluating the safety, tolerability, pharmacokinetics/pharmacodynamics, and preliminary antitumor activity of intraperitoneally administered SY001…
- Trial name
- NCT07909434
- Testing
- SY001
- Volunteers
- 10 people
- Sponsor
- Zhejiang University
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.